GERN SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Geron Corporation (GERN)
CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:
If you suffered Geron losses, you may CLICK HERE or copy and paste the following link into your browser: https://www.ktmc.com/new-cases/geron-corporation?utm_source=PR&utm_medium=link&utm_campaign=gern&mktm=r
You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected].
DEFENDANTS' ALLEGED MISCONDUCT:
The complaints allege that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Defendants created the false impression that they possessed reliable information pertaining to Geron's projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations; (2) in truth, Geron's optimistic reports of its primary product, RYTELO's, launch success and potential growth fell short of reality as the impacts of seasonality, existing competition, and the burden of continued monitoring played a much more significant role in patient starts than Defendants had implied; (3) RYTELO lacked the necessary awareness to penetrate the market, resulting in an inability for Geron to capitalize on the purportedly significant unmet need for the drug, particularly among first-line patients and those outside the academic setting; and (4) as a result, Defendants' statements about the company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
THE LEAD PLAINTIFF PROCESS:
Geron investors may, no later than May 12, 2025, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.
Kessler Topaz Meltzer & Check, LLP encourages Geron investors who have suffered significant losses to contact the firm directly to acquire more information.
CLICK HERE TO SIGN UP FOR THE CASE OR GO TO: https://www.ktmc.com/new-cases/geron-corporation?utm_source=PR&utm_medium=link&utm_campaign=gern&mktm=r
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world. The firm has developed a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by businesses and fiduciaries. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.
CONTACT:
Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.|
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
[email protected]
May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
TI Chief Financial Officer Rafael Lizardi to speak at Citi investor conference
Sept. 4, 2025, 8:10 a.m. Eastern time DALLAS, Aug. 20, 2025 /PRNewswire/ -- Texas Instruments Incorporated (TI) (Nasdaq: TXN) Senior Vice President and Chief Financial Officer Rafael Lizardi will speak at the Citi 2025 Global TMT Conference in New York City on Thursday, Sept. 4, at 8:10 a.m. Eastern time. Lizardi will field questions from analysts and investors, as well as discuss TI's business outlook and its strategy to address key markets for its analog and embedded processing technologies and how these capabilities position the company for growth. The audio webcast for the conference can be accessed live through the Investor Relations section ( of TI's website. An archived replay will be available on the website after his remarks. About Texas Instruments Texas Instruments Incorporated (Nasdaq: TXN) is a global semiconductor company that designs, manufactures and sells analog and embedded processing chips for markets such as industrial, automotive, personal electronics, enterprise systems and communications equipment. At our core, we have a passion to create a better world by making electronics more affordable through semiconductors. This passion is alive today as each generation of innovation builds upon the last to make our technology more reliable, more affordable and lower power, making it possible for semiconductors to go into electronics everywhere. Learn more at TXN-G View original content to download multimedia: SOURCE Texas Instruments Incorporated
Yahoo
an hour ago
- Yahoo
Analog Devices Shares Jump After Blowout Quarter and Upbeat Forecast
This article first appeared on GuruFocus. Aug 20 - Analog Devices (NASDAQ:ADI) gained roughly 4% on Wednesday after reporting fiscal third-quarter results that topped Wall Street expectations and offering stronger-than-expected guidance for the current quarter. The move came even as most other semiconductor stocks traded lower. Warning! GuruFocus has detected 11 Warning Signs with ADI. Revenue in the third quarter rose about 4% above consensus and exceeded the high end of the company's guided range. Communications and Consumer segments delivered notable strength, with sales beating analyst forecasts by 15% and 6%, respectively. Management projected fiscal fourth-quarter revenue to grow 4% sequentially, which is 6% ahead of consensus expectations. Analysts were quick to weigh in. Wells Fargo reiterated an Equal Weight rating with a $235 price target, noting solid bookings and pointing to forward visibility as a key factor for recovery heading into fiscal 2026. Evercore maintained its Outperform rating with a $280 price target, citing the revenue beats and robust demand outlook. Truist kept its Hold rating and $219 price target, highlighting that tariffs and trade fluctuations still cloud the broader market backdrop. With macro uncertainty continuing, investors seem buoyed by the fact that Analog Devices is able to move through the changing environment and still show a high level of demand in the most important markets.

Yahoo
an hour ago
- Yahoo
UBS sees buy opportunity in Microsoft as pricing changes boost cloud revenues
-- UBS said in a note on Wednesday that Microsoft's latest pricing and licensing changes are likely to drive stronger cloud revenues, reinforcing its Buy rating on the stock. 'Last week, Microsoft (NASDAQ:MSFT) announced a new pricing and licensing model that partners described as 'significant' and 'very aggressive,' prompting us to explore the change in detail,' UBS analysts wrote. The bank said Microsoft is 'standardizing pricing across most of its customer tiers on EA contract types, with partners consistent in their feedback that this results in a net price increase.' The changes, effective Nov. 1, will apply to Microsoft's Online Services suite, including Azure, Microsoft 365/Office 365, and Dynamics 365. UBS estimated these products represent about 55% of revenues. Government and education contracts, as well as on-premise products, are exempt. According to partners cited by UBS, the net price increase ranges between '3-6% to 10-14%.' UBS stated that it assumes the new pricing was reflected in Microsoft's guidance and that the firm now has 'marginally more confidence in our outlook for total c/c revenue growth of 14% in FY26E.' Analysts cautioned, however, that the benefits may be gradual because the increases apply as contracts renew and do not cover Microsoft's largest global accounts. The bank also noted that 'partners flagged a series of separate pricing/licensing changes that Microsoft has been making on its on-prem suite that we conclude could have accelerated Azure migration activity of late.' UBS kept its $650 price target and Buy rating on MSFT unchanged, citing the company's strong positioning in artificial intelligence. 'We still view the stock as being reasonably priced given how levered Microsoft is to the AI phenomenon,' the analysts said. Related articles UBS sees buy opportunity in Microsoft as pricing changes boost cloud revenues Clients buying into summer rally, bracing for later pullback, says BofA's Hartnett After soaring 149%, this stock is back in our AI's favor - & already +25% in July